Retrospective cohort study of 148 patients with polyclonal gammopathy

Mayo Clinic Proceedings

Volumn 76, Issue 5, 2001, Pages 476-487

  Dispenzieri, Angela ^a   Gertz, Morie A ^a   Therneau, Terry M ^a   Kyle, Robert A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CLONAL ANERGY; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; FEMALE; GAMMOPATHY; HUMAN; HYPERGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; MALE; PLASMA CELL; POLYCLONAL ACTIVATION; PROTEIN ELECTROPHORESIS; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOCYTE COUNT;

EID: 0035033533     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.5.476     Document Type: Article

References (117)

1. Ogryzlo MA, Maclachlan M, Dauphinee JA, Fletcher AA. The serum proteins in health and disease: filter paper electrophoresis. AmJMed. 1959;27:596-616.
2. Miller RG. Simultaneous Statistical Inference. 2nd ed. New York, NY: Springer-Verlag; 1981.
3. Conover WJ. Practical Nonparametric Statistics. 2nd ed. New York, NY: Wiley; 1980.
4. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980.
5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
6. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980.
7. Madrenas J, Curull V, Barbero L, Vidai R, Morell F. Non immunological analytic data for the differential diagnosis between miliary tuberculosis (MTBC) and bird breeder's disease (BED). Allergol Immunopathol (Madr). 1985;13:301-304.
8. Waldenström JG. Monoclonal and Polyclonal Hypergammaglobulinemia: Clinical and Biological Significance. Nashville, Tenn: Vanderbilt University Press; 1968.
9. Waldenström J. Forty years with the gamma globulins. Scand J Immunol. 1987;25:211-218.
10. Waldenström J. Studies of conditions associated with disturbed gammaglobulin formation (gammopathies). Harvey Led. 1961; 57:211-231.
11. Kogawa K, Hisai H, Morii K, et al. T-cell mediated polyclonal B-cell activation in a case of B-cell lymphoma associated with polyclonal hypergammaglobulinemia. Int J Hematol. 1995;62: 253-257.
12. Jourdan M, Bataille R, Seguin J, Zhang XG, Chaptal PA, Klein B. Constitutive production of interleukin-6 and immunologie features in cardiac myxomas. Arthritis Rheum. 1990;33:398402.
13. + T cell-B cell antibody synthesis. J Clin Immunol. 1996;16:198207.
14. Kelton JG, Singer J, Rodger C, Gauldie J, Horsewood P, Dent P. The concentration of IgG in the serum is a major determinant of Fc-dependent reticuloendothelial function. Blood. 1985;66: 490-495.
15. Mutchnick MG, Lederman HM, Missirian A, Johnson AG. In vitro synthesis of IgG by peripheral blood lymphocytes in chronic liver disease. Clin Exp Immunol. 1981;43:370-375.
16. Holdstock G, Ershler WB, Krawitt EL. Demonstration of non-specific B-cell stimulation in patients with cirrhosis. Gut. 1982:23:724-728.
17. Czaja AJ. Autoimmune liver disease. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. Vol 2. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1996:1259-1292.
18. Kay RA, Hay EM, Dyer PA, et al. An abnormal T cell repertoire in hypergammaglobulinaemic primary Sjögren's syndrome. Clin Exp Immunol. 1991;85:262-264.
19. Bell DA, Komar R, Chodirker WB, Block J, Cairns E. A comparison of sérologie reactivity among SLE patients with or without anti-Ro (SS-A) antibodies. J Rheumaiol. 1984; 11:315-317.
20. Spronk PE, Gun BT, Limburg PC, Kallenberg CG. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation. Clin Exp Immunol. 1993;93: 39-44.
21. Hameenkorpi R, Ruuska P, Forsberg S, Tiilikainen R, Makitalo R, Hakala M. More evidence of distinctive features of mixed connective tissue disease. Scand J Rheumatol. 1993;22:63-68.
22. Caporali R, Scatola C, Montecucco C. Benign hypergammaglobulinemic purpura and anti-Ro (SSA) antibodies in undifferentiated connective tissue disease. J Rheumatol. 1996;23: 410-411.
23. Katayama I. Clinical analysis of recurrent hypergammaglobulinemic purpura associated with Sjögren syndrome. J Dermatol. 1995;22:186-190.
24. McGovern TW, Erickson AR, Fitzpatrick JE. Sjögren's syndrome plasma cell panniculitis and hidradenitis. J Cutan Pathol. 1996; 23:170-174.
25. Caspi D, Fishel R, Varon M, Yona E, Baratz M, Yaron M. Multisystem presentation of eosinophilic fasciitis. Rheumatol Rehabil 1982;21:218-221.
26. Shulman LE. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol. 1984:11: 569-570.
27. Beaucher WN. Fasciitis with eosinophilia: a case report. N Engt Reg Allergy Proc. 1985;6:374-376.
28. Lehtinen K. The mortality and causes of death of patients with "hypergamma type" of ankylosing spondylitis. Scand J Rheumatol. 1983;12:3-4.
29. Moutsopoulos HM, Constantopoulos S, Gerber LH, Lawley TJ. Immunologie abnormalities in idiopathic Raynaud's phenomenon. Clin Exp Rheumatol. 1983; 1:45-48.
30. Ben-Chetrit E, Fox RI, Tan EM. Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum. 1990;33:349-355.
31. Ehrenstein MR, Isenberg DA. Hypergammaglobulinaemia and autoimmune rheumatic diseases. Ann Rheum Dis. 1992;51:11851187.
32. Steinberg AD, Seldin MF, Jaffe ES, et al. NIH conference: angioimmunoblastic lymphadenopathy with dysproteinemia. Ann Intern Med. 1988:108:575-584.
33. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood. 1993:82:1-14.
34. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997;89:256-260.
35. Bassan R, Pronesti M, Buzzetti M, et al. Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells. Cancer. 1989:63:90-95.
36. Mouzaki A, Matthes T, Miescher PA, Beris P. Polyclonal hypergammaglobulinaemia in a case of B-cell chronic lymphocytic leukaemia: the result of IL-2 production by the proliferating monoclonal B cells? BrJHaematol. 1995;91:345-349.
37. Miller RH, Linet MS, Van Natta ML, McCaffrey LD, Humphrey RL. Serum protein electrophoresis patterns in chronic lymphocytic leukemia: clinical and epidemiologic correlations. Arch Intern Med. 1987;147:1614-1617.
38. Economopoulos T, Economidou J, Giannopoulos G, et al. Immune abnormalities in myelodysplastic syndromes. J Clin Pathol. 1985;38:908-911.
39. Mufti GJ, Figes A, Hamblin TJ, Oscier DG, Copplestone JA. Immunological abnormalities in myelodysplastic syndromes, I: serum immunoglobulins and autoantibodies. Br J Haematol. 1986;63:143-147.
40. Solal-Celigny P, Desaint B, Herrera A, et al. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood. 1984;63:634-638.
41. Tatsuno I, Nishikawa T, Sasano H, Shizawa S. Iwase H, Satoh S. Interleukin 6-producing gastric carcinoma with fever, hypergammaglobulinemia, and plasmacytosis in bone marrow. Gastroenterology. 1994; 107:543-547.
42. Gotoh T, Takishita Y, Doi H, Tsubura E. Secretory-componentproducing lung cancer with hypergammaglobulinemia of secretory IgA. Cancer. 1981;48:1776-1782.
43. Case records of the Massachusetts General Hospital. N Engl J Med. 1997:337:1612-1619. Case 37-1997.
44. Wheeler WB, Williams M, Matthews WJ Jr, Gölten HR. Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr. 1984;104:695-699.
45. Moss RB. Hypergammaglobulinemia in cystic fibrosis: role of Pseudomonas endobronchial infection. Chest. 1987;91:522-526.
46. Jones MM, Seilheimer DK, Pollack MS, Curry M, Crane MM, Rossen RD. Relationship of hypergammaglobulinemia, circulating immune complexes, and histocompatibility antigen profiles in patients with cystic fibrosis. Am Rev Respir Dis. 1989; 140: 1636-1639.
47. Reimer CB, Black CM, Holman RC, et al. Hypergammaglobulinemia associated with human immunodeficiency virus infection. Monogr Allergy. 1988;23:83-96.
48. Kekow J, Hobusch G, Gross WL. Predominance of the IgGl subclass in the hypergammaglobulinemia observed in pre-AIDS and AIDS. Cancer Detect Prev. 1988; 12:211-216.
49. Jacobson DL. McCutchan JA, Spechko PL, et al. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. J Infect Dis. 1991 ; 163: 240-246.
50. Wang CR, Liu MF, Jeng GW, et al. Autoantibodies and related immunity of leprosy patients from leprosarium in Taiwan. Chung Hua Min Kuo Wei Sheng Wu Chi Mien I Hsueh Tsa Chih. 1992: 25:181-188.
51. Baji PS, Kher JR, Ganeriwal SK, Reddy BV, Bulakh PM. Electrophoretic pattern of proteins in lepromatous leprosy. Lepr India. 1982;54:82-94.
52. Yu KW, Chow MP, Hsu NW, et al. Imported kala-azar: a case report. Chung Him I Hsueh Tsa Chih (Taipei). 1992;50:411-414.
53. Grauert MR, Houdayer M, Hontebeyrie-Joskowciz M. Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease. Clin Exp Immunol. 1993: 93:85-92.
54. Fanning M, Hill A, Langer HM, Keystone JS. Visceral larva migrans (toxocariasis) in Toronto. Can Med Assoc J. 1981; 124: 21-26.
55. Oyeyinka GO. The role of mitogenic factors in the pathogenesis of certain features of malarial infection. Afr J Med Med Sci. 1988; 17:201-207.
56. Vital C, Deminiere C, Lagueny A, et al. Peripheral neuropathy with essential mixed cryoglobulinemia: biopsies from 5 cases. Acta Neuropathol (Berl). 1988;75:605-610.
57. Kyle RA, Dyck PJ. Neuropathy associated with the monoclonal gammopathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. Vol 2. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1993:12751287.
58. Kelly JJ Jr, Kyle RA, O' Brien PC, Dyck PJ. Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 1981;31: 1480-1483.
59. Latov N, Sherman WH, Nemni R, et al. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheralnerve myelin. N EnglJ Med. 1980;303:618-621.
60. Maisonobe T, Chassande B, Vérin M, Jouni M, Léger JM, Bouche P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J Neural Neurosurg Psychiatry. 1996;61:36-42.
61. Mori M, Kinoshita K, Ban N, Yamada Y, Shiku H. Activated T-lymphocytes with polyclonal gammopathy in patients with human T-lymphotropic virus type I-associated myelopathy. Ann Neural. 1988;24:280-282.
62. Sobue G, Yanagi T, Hashizume Y. Chronic progressive sensory ataxic neuropathy with polyclonal gammopathy and disseminated focal perivascular cellular infiltrations. Neurology. 1988;38: 463-467.
63. Dalakas MC. Chronic idiopathic ataxic neuropathy. Ann Neural. 1986;19:545-554.
64. Shy ME, Rowland LP, Smith T, et al. Motor neuron disease and plasma cell dyscrasia. Neurology. 1986;36:1429-1436.
65. Powell HC, Rodriguez M, Hughes RA. Microangiopathy of vasa nervorum in dysglobulinemic neuropathy. Ann Neural. 1984; 15: 386-394.
66. Watanabe N, Kobayashi M, Shigeta Y, Hara H. Chronic idiopathic neutropenia with hypergammaglobulinemia. Jpn J Med. 1987;26:65-68.
67. Goldsmith JM, Kalish SB, Green D, Chmiel JS, Wallemark CB, Phair JP. Sequential clinical and immunologie abnormalities in hemophiliacs. Arch Intern Med. 1985; 145:431 -434.
68. Beddall AC, Al-Rubei K, Williams MD, Hill FG. Lymphocyte subset ratios and factor VIII usage in haemophilia. Arch Dis Child. 1985;60:530-536.
69. Shannon BT, Roach J, Cheek-Luten M, Orosz C, Ruymann FB. Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia. J Clinlmmunol. 1986;6:121-129.
70. Matheson DS, Green BJ, Fritzler MJ, Poon MC, Bowen TJ, Hoar DI. Humoral immune response in patients with hemophilia. Clin Immunol Immunopathol. 1987 ;44:41-50.
71. Dwyer J, Wood C, McNamara J, et al. Abnormalities in the immune system of children with beta-thalassaemia major. Clin Exp Immunol. 1987;68:621-629.
72. Dessi C, Clémente MG, Diana G, et al. Cryoglobulinemia in transfusion-dependent thalassemia major. Clin Exp Rheumatol. 1995;13(suppl 13):149S-151S.
73. Al-Awamy BH, Niazi GA, Al-Mouzan Ml, Al-Nahdi M, Naeem MA, Sumer T. Sérum immunoglobulin and complement levels in patients with sickle cell anaemia from eastern province of Saudi Arabia. Trap Geogr Med. 1988;40:13-16.
74. Saini RK, Sharma SK, Sharma SK. Fanconi's anaemia with psoriasis and polyclonal gammopathy. J Indian Med Assoc. 1984; 82:327-328.
75. Buchanan WW, Koutras DA, Alexander WD, Crooks J. Serum proteins in thyroid disease. BMJ. 1962;! :979-982.
76. Briones-Urbina R, Bear JC, Farid NR. Association of hypergammaglobulinemia G with HLA-DR3 in Graves' disease. Tissue Antigens. 1982; 19:20-24.
77. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-1568.
78. Mana J, Salazar A, Pujol R, Manresa F. Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis? Respiration. 1996;63:298-303.
79. Baughman RP, Hurtubise PE. Systemic immune response of patients with active pulmonary sarcoidosis. Clin Exp Immunol. 1985;61:535-541.
80. Kishimoto S, Yasuno H, Ikada J. A case of sarcoidosis which relapsed twice after successive parturitions. J Dermatol. 1995;22: 953-957.
81. Shield JP, Strobel S, Levinsky RJ, Morgan G. Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency. Lancet. 1992;340:448-450.
82. Lindstrom F, Eriksson P, Denneberg T, Almroth G. IgG2 deficiency in patients with hypergammaglobulinaemia [letterJ. Lancet. 1992;340:979.
83. Jeandel C, Gueant JL, Petipain N, Laurain MC, Jouanny MD. Hypergammaglobulinaemia and IgG subclass deficiency [letterJ. Lancet. 1992;340:1225-1226.
84. Spinozzi F, Agea E, Gerli R, Muscat C, Bistoni O, Bertotto A. Hypergammaglobulinaemia and IgG subclass deficiency [letterJ. Lancet. 1992;340:1225.
85. Venuta A, Penza R, Cellini M, et al. Primary hypergammaglobulinemic purpura associated with IgG2 deficiency: a case report. Clin Exp Rheumatol. 1995; 13:663-665.
86. Drenth JP, Haagsma CJ, van der Meer JW, International HyperIgD Study Group. Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. Medicine (Baltimore). 1994;73:133-144.
87. Ochs HD, Wedgwood RJ. Disorders of the B-cell system. In: Stiehm ER, ed. Immunologie Disorders in Infants and Children. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1989:226-256.
88. Marti GE, Ryan ET, Papadopoulos NM, et al. Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol. 1988;29:189-194.
89. Laks Y, Passwell J. The varied clinical and laboratory manifestations of type II Gaucher's disease. Acta Paediatr Scand. 1987; 76:378-380.
90. Shoenfeld Y, Gallant LA, Shaklai M, Livni E, Djaldetti M, Pinkhas J. Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med. 1982;106:388-391.
91. Patel SC, Davis GL, Barranger JA. Gaucher's disease in a patient with chronic active hepatitis. Am J Med. 1986;80:523-525.
92. Tomoda K, Suzuka Y, Iwai H, Yamashita T, Kumazawa T. Meniere's disease and autoimmunity: clinical study and survey. Acta Otolaryngol Suppl (Stockh). 1993;500:31-34.
93. Wang HT, Tsai CY, Chang HN, Shih CM, Yu CL. Prolonged elevation of antinuclear antibodies in a patient with atrial myxoma after tumor extirpation [letter], din Exp Rheumatol. 1995;13:676-677.
94. deShazo RD, Daul CB, Morgan JE, et al. Immunologie investigations in asbestos-exposed workers. Chest. 1986;89(suppl 3):162S-165S.
95. Takekawa H, Munakata M, Saiki S, Kawakami Y. A patient with cryptogenic organizing pneumonitis who presented with multiple patchy shadows. Nippon Kyobu Shikkan Gakkai Zasshi. 1995; 33:780-784.
96. Torii K, Ogawa K, Kawabata Y, Yokoi T, Takagi K, Miwa T. Lymphoid interstitial pneumonia as a pulmonary lesion of idiopathic plasmacytic lymphadenopathy with hyperimmunoglobulinemia. Intern Med. 1994;33:237-241.
97. Yoshizawa Y, Ohdama S, Ikeda A, Ohtsuka M, Masuda S, Tanaka M. Lymphoid interstitial pneumonia associated with depressed cellular immunity and polyclonal gammopathy. Am Rev Respir Dis. 1984; 130:507-509.
98. McCurdy DK, Cornwell GG III, DePratti VJ. Hyperglobulinemic renal tubular acidosis: report of two cases. Ann Intern Med. 1967; 67:110-117.
99. Fourman P, McCance RA. Tetany complicating the treatment of potassium deficiency in renal acidosis. Lancet. 1955;1:329331.
100. Lerner B A, Brickner PW. Renal tubular acidosis and potassium \oss.AmJMed. 1959;27:664-672.
101. Talal N, Zisman E, Schur PH. Renal tubular acidosis, glomerulonephritis and immunologie factors in Sjögren's syndrome. Arthritis Rheum. 1968;ll:774-786.
102. Morris RC Jr, Fudenberg HH. Impaired renal acidification in patients with hypergammaglobulinemia. Medicine (Baltimore). 1967;46:57-69.
103. Mason AM, Golding PL. Hyperglobulinaemic renal tubular acidosis: a report of nine cases. BMJ. 1970;3:143-146.
104. Feest TG, Lockwood CM, Morley AR, Uff JS. Renal histology and immunopathology in distal renal tubular acidosis. Clin Nephrol. 1978;10:187-190.
105. Vladutiu AO, Roach BM, Farahmand SM. Polyclonal gammopathy with marked increase in serum viscosity. Clin Chem. 1991;37:1788-1793.
106. Eaton AM, Serota H, Kernodle GW Jr, Uglietta JP, Crawford J, Fulkerson WJ. Pulmonary hypertension secondary to serum hyperviscosity in a patient with rheumatoid arthritis. Am J Med. 1987;82:1039-1045.
107. Sarnat RL, Jampot LM. Hyperviscosity retinopathy secondary to polyclonal gammopathy in a patient with rheumatoid arthritis. Ophthalmology. 1986;93:124-127.
108. Fukasawa T, Arai T, Naruse T, Maekawa T. Hyperviscosity syndrome in a patient with systemic lupus erythematosus. Am J Med Sci. 1977;273:329-334.
109. Blaylock WM, Waller M, Normansell DE. Sjögren's syndrome: hyperviscosity and intermediate complexes. Ann Intern Med. 1974;80:27-34.
110. Alarçon-Segovia D, Fishbein E, Abruzzo JL, Heimer R. Serum hyperviscosity in Sjögren's syndrome interaction between IgG and IgG rheumatoid factor. Ann Intern Med. 1974;80:35-42.
111. Martin CM, Matlow AG, Chew E, Sutton D, Pruzanski W. Hyperviscosity syndrome in a patient with acquired immunodeficiency syndrome. Arch Intern Med. 1989;149:1435-1436.
112. Lee WM, Lebwohl O, Chien S. Hyperviscosity syndrome attributable to hyperglobulinemia in chronic active hepatitis. Gastroenterology. 1978;74:918-921.
113. Hadler NM, Gabriel D, Su Chung K, league P, Napier MA. Polyclonal hyperviscosity syndrome. Arthritis Rheum. 1977;20: 1388-1395.
114. Steinberg JJ, Huang PL, Ljubich P, Lee-Huang S. And- erythropoietin antibodies in hyperviscosity syndrome associated with giant lymph node hyperplasia (GLNH; Castleman's disease). Br J Haematol. 1990;74:543-544.
115. Gertz MA, Kyle RA. Hyperviscosity syndrome. J Intensive Care Med. 1995:10:128-141.
116. Nanji AA, Campbell DJ, Pudek MR. Decreased anion gap associated with hypoalbuminemia and polyclonal gammopathy. JAMA. 1981;246:859-860.
117. Heddle NM, Kelton JG, Turchyn KL, Ali MA. Hypergammaglobulinemia can be associated with a positive direct antiglobulin test, a nonreactive eluate, and no evidence of hemolysis. Transfusion. 1988:28:29-33.